CLEARPOINT NEURO INC
CLPTNASDAQTrading Snapshot
- Day Range
- $10.66 β $11.94
- 52-Week Range
- $8.27 β $27.27
- Volume (shares)
- 53,391
- Avg Volume (shares)
- β
- Shares Outstanding
- 30.5M
- Next Earnings
- 2027-03-03
Fundamentals Snapshot
- Annual Revenue
- $37M
- Last Q Revenue
- $11M
- P/E Ratio
- β
- P/S Ratio
- 7.6x
- EPS (TTM)
- $-1.18
- Dividend Yield
- β
- Dilution (1yr)
- +4.8%
CLEARPOINT NEURO INC
CLPTAbout CLEARPOINT NEURO INC
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
News unavailable.